Unexpected Toxicity of Cyclophosphamide Followed by Adoptively Transferred CD19-Targeted T Cells in a Patient with Bulky CLL

被引：0
|
作者：
Brentjens, Renier J. [1 ]
Riviere, Isabelle [1 ]
Hollyman, Daniel [1 ]
Taylor, Clare [1 ]
Nikhamin, Yan [1 ]
Stefanski, Jolanta [1 ]
Lee, James [1 ]
Yeh, Raymond [1 ]
Santos, Elmer [1 ]
Sadelain, Michel [1 ]
机构：
[1] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA
来源：
MOLECULAR THERAPY | 2009年 / 17卷
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
401
引用
收藏
页码：S157 / S157
页数：1
相关论文
共 50 条
  • [21] CD19-targeted CAR regulatory T cells suppress B cell pathology without GvHD
    Imura, Yuki
    Ando, Makoto
    Kondo, Taisuke
    Ito, Minako
    Yoshimura, Akihiko
    JCI INSIGHT, 2020, 5 (14)
  • [22] Extracellular Vesicles Expressing CD19 Antigen Improve Expansion and Efficacy of CD19-Targeted CAR-T Cells
    Zhang, Yuanyuan
    Ge, Tong
    Huang, Meijuan
    Qin, Yun
    Liu, Tianjiao
    Mu, Wei
    Wang, Gaoxiang
    Jiang, Lijun
    Li, Tongjuan
    Zhao, Lei
    Wang, Jue
    INTERNATIONAL JOURNAL OF NANOMEDICINE, 2023, 18 : 49 - 63
  • [23] Outcome correlates of approved CD19-targeted CAR T cells for large B cell lymphoma
    Bock, Tamara J.
    Colonne, Chanukya K.
    Fiorenza, Salvatore
    Turtle, Cameron J.
    NATURE REVIEWS CLINICAL ONCOLOGY, 2025, : 241 - 261
  • [24] CD19-Targeted CAR T Cells: A New Tool in the Fight against B Cell Malignancies
    Miller, Brian C.
    Maus, Marcela V.
    ONCOLOGY RESEARCH AND TREATMENT, 2015, 38 (12) : 683 - 690
  • [25] Novel Chimeric Antigen Receptor T Cells for the Treatment of CD19-Negative Relapses Occurring after CD19-Targeted Immunotherapies
    Ruella, Marco
    Barrett, David
    Kenderian, Saad S.
    Shestova, Olga
    Hofmann, Ted J.
    Scholler, John
    Lacey, Simon F.
    Melenhorst, Jan J.
    Nazimuddin, Farzana
    Kalos, Michael
    Porter, David L.
    June, Carl H.
    Grupp, Stephan A.
    Gill, Saar I.
    BLOOD, 2014, 124 (21)
  • [26] Clinical Immunotherapy of B-Cell Malignancy Using CD19-Targeted CAR T-Cells
    Maher, John
    CURRENT GENE THERAPY, 2014, 14 (01) : 35 - 43
  • [27] Impact of the Conditioning Chemotherapy On Outcomes in Adoptive T Cell Therapy: Results From a Phase I Clinical Trial of Autologous CD19-Targeted T Cells for Patients with Relapsed CLL
    Park, Jae H.
    Riviere, Isabelle
    Wang, Xiuyan
    Stefanski, Jolanta
    He, Qing
    Taylor, Clare
    Olszewska, Malgorzata
    Wasielewska, Teresa
    Bartido, Shirley
    Davila, Marco L.
    Bernal, Yvette
    Lamanna, Nicole
    Noy, Ariela
    Sadelain, Michel
    Brentjens, Renier J.
    BLOOD, 2012, 120 (21)
  • [28] CD19-Targeted T Cells Rapidly Induce Molecular Remissions in Adults with Chemotherapy Refractory Acute Leukemia
    Brentjens, Renier
    Davila, Marco L.
    Riviere, Isabelle
    Park, Jae
    Wang, Xiuyan
    Bartido, Shirley
    Stefankski, Jolanta
    Borquez-Ojeda, Oriana
    Bernal, Yvette
    Sadelain, Michel
    MOLECULAR THERAPY, 2013, 21 : S196 - S196
  • [29] Donor CD19-targeted T cells exert potent graft versus lymphoma activity without GVHD
    Ghosh, Arnab
    Davila, Marco
    Young, Lauren
    Jenq, Robert
    Sadelain, Michel
    van den Brink, Marcel
    JOURNAL OF IMMUNOLOGY, 2013, 190
  • [30] Treatment of secondary CNS lymphoma using CD19-targeted chimeric antigen receptor (CAR) T cells
    Kathryn Kline
    Tim Luetkens
    Rima Koka
    Michael E. Kallen
    Wengen Chen
    Haroon Ahmad
    Destiny Omili
    Thierry Iraguha
    Etse Gebru
    Xiaoxuan Fan
    Alexis Miller
    Nishanthini Dishanthan
    Jillian M. Baker
    Kenneth A. Dietze
    Kim G. Hankey
    Jean A. Yared
    Nancy M. Hardy
    Aaron P. Rapoport
    Saurabh Dahiya
    Djordje Atanackovic
    Cancer Immunology, Immunotherapy, 73
12345